Skip to main content

Table 5 Upstream regulators induced by L-OHP treatment in HT-29R

From: Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins

Upstream regulator

Log ratio

Molecule type

Predicted activation state

z-score

p-value of overlap

Target molecules in dataset

TGM2

0.968

Enzyme

Activated

4.762

8.90E-09

DDX60, DDX60L, DEFA1, HIP1, IFI6, IFIT1, IFIT2, IFIT3, IFIT5, IRF9, MT2A, OAS3, OASL, PARP9, PHLDA1, PLSCR1, RARRES3, RUNX2, SAMD9L, SLFN5, STAT1, TGFB1, XAF1

STAT1

0.855

Transcription regulator

Activated

3.592

1.47E-08

AGT, ALDH1A3,CLIC5, DPP4, HERC6, IFI27, IFI6, IFIT1, IFIT2, IFITM1, IRF9, ISG15, KCTD12, PSMB8, PSMB9, PTGS2, RUNX1, SLFN5, STAT1, TLR3, TYMP, USP18

TLR3

0.624

Transmembrane receptor

Activated

3.392

5.85E-07

DHX58, IFI44, IFI44L, IFI6, IFIH1, IFIT1,IFIT2, IFIT3, IFNE, ISG15, MX1, MX2, OASL, PHLDA1, PLK2, PTGS2, STAT1, TLR3, USP18

INSIG1

-2.061

Other

Activated

3.039

1.74E-06

CXCR4, CYP51A1, DHCR7, HMGCS1, HMGCS2, IDI1, LDLR, PLD1, SCD, SQLE, SREBF1, STARD4,TGFB1

NFATC2

0.635

Transcription regulator

Activated

3.019

3.84E-05

IFIT2, ISG15, LMO4, MX1, OASL, PLD1, PLK2, PTGS2, SH3BP5, SLCO3A1, STAT1, TGFB1,T LR3

IFNE

0.861

Cytokine

Activated

2.804

2.07E-07

IFIH1, IFIT2, MX2, PTGS2, RARRES3, STAT1, TLR3, USP18

PARP9

1.087

Other

Activated

2.433

1.24E-06

IFI44, IFIT1, IFIT2, IFIT3, ISG15, STAT1

IFIH1

0.742

Enzyme

Activated

2.190

2.68E-04

BST2, ISG15, MX1, PHLDA1, RND3

SREBF1

-0.624

Transcription regulator

Inhibited

-2.980

1.36E-07

CAMK1D, CYP51A1, DHCR7, HMGCS1, HNF4A, IDI1, INSIG1, LDLR, MSMO1, NR0B2, PNPLA3, PTGS2, SCD, SQLE, SREBF1, STARD4,T GFB1, VEGFA

USP18

0.941

Peptidase

Inhibited

-2.219

5.62E-05

IFI6, IFITM3, IRF9, ISG15, MX1